CENTURY THERAPEUTICS INC. - COMMON STOCK

Century Therapeutics Receives Study May Proceed Notification from FDA for CNTY-101, the First Allogeneic Cell Therapy Product Candidate Engineered to Overcome Three Major Pathways of Host vs Graft Rejection

25 أغسطس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

11 أغسطس 2022 07:30:01 بحسب Nasdaq GlobeNewswire

Century Therapeutics Announces Its Addition to the Russell Microcap® Index

24 يونيو 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

21 يونيو 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Host Virtual Research and Development Day on June 13, 2022

06 يونيو 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates

16 مايو 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at Upcoming Investor Conferences

03 مايو 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the Chardan Genetic Medicines and Cell Therapy Manufacturing Summit

18 أبريل 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

06 أبريل 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the H.C. Wainwright Gene Therapy and Gene Editing Conference

23 مارس 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics Reports Fourth Quarter and Year-end 2021 Financial Results and Provides Business Updates

17 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

09 فبراير 2022 16:05:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies

10 يناير 2022 06:59:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

04 يناير 2022 16:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics Added to the NASDAQ Biotechnology Index

17 ديسمبر 2021 07:00:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics Announces Presentation of Data at the 63rd American Society of Hematology Annual Meeting and Provides Pipeline Updates

16 ديسمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

22 نوفمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Century Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates

10 نوفمبر 2021 07:30:01 بحسب Nasdaq GlobeNewswire

Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update

04 نوفمبر 2021 09:00:03 بحسب Nasdaq GlobeNewswire

Century Therapeutics and Outpace Bio Enter Research Collaboration in CAR Engineering

07 أكتوبر 2021 07:30:00 بحسب Nasdaq GlobeNewswire